BR112017005392A2 - amplificação de ácido nucleico multipassos híbrida - Google Patents

amplificação de ácido nucleico multipassos híbrida

Info

Publication number
BR112017005392A2
BR112017005392A2 BR112017005392A BR112017005392A BR112017005392A2 BR 112017005392 A2 BR112017005392 A2 BR 112017005392A2 BR 112017005392 A BR112017005392 A BR 112017005392A BR 112017005392 A BR112017005392 A BR 112017005392A BR 112017005392 A2 BR112017005392 A2 BR 112017005392A2
Authority
BR
Brazil
Prior art keywords
multiphase
hybrid
nucleic acid
acid amplification
amplification
Prior art date
Application number
BR112017005392A
Other languages
English (en)
Inventor
Richardson Aaron
Wu Indira
Lee Josephine
Belhocine Kamila
Patel Pranav
Tabakman Scott
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/056151 external-priority patent/WO2015076919A1/en
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of BR112017005392A2 publication Critical patent/BR112017005392A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BR112017005392A 2014-09-17 2015-09-17 amplificação de ácido nucleico multipassos híbrida BR112017005392A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462051912P 2014-09-17 2014-09-17
US201462051945P 2014-09-17 2014-09-17
PCT/US2014/056151 WO2015076919A1 (en) 2013-11-22 2014-09-17 Nucleic Acid Amplification
US201462068603P 2014-10-24 2014-10-24
US201462068605P 2014-10-24 2014-10-24
US201562151358P 2015-04-22 2015-04-22
PCT/US2015/050822 WO2016044673A1 (en) 2014-09-17 2015-09-17 Hybrid multi-step nucleic acid amplification

Publications (1)

Publication Number Publication Date
BR112017005392A2 true BR112017005392A2 (pt) 2017-12-12

Family

ID=55533878

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005392A BR112017005392A2 (pt) 2014-09-17 2015-09-17 amplificação de ácido nucleico multipassos híbrida

Country Status (8)

Country Link
US (3) US9909193B2 (pt)
EP (2) EP3194629A4 (pt)
JP (6) JP2017532030A (pt)
CN (3) CN108026591B (pt)
BR (1) BR112017005392A2 (pt)
CA (2) CA2961209A1 (pt)
MX (2) MX366113B (pt)
WO (2) WO2016044673A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044673A1 (en) 2014-09-17 2016-03-24 Theranos, Inc. Hybrid multi-step nucleic acid amplification
US10822648B1 (en) 2016-07-29 2020-11-03 Labrador Diagnostics Llc Hybrid multi-step nucleic acid amplification
CA3046504A1 (en) 2016-12-15 2018-06-21 Meharry Medical College Antiviral agents
FI130673B1 (en) * 2020-11-24 2024-01-11 Mobidiag Oy Method and system for performing a cumulative nucleic acid amplification reaction

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA2255774C (en) * 1996-05-29 2008-03-18 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6743605B1 (en) * 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
ES2464132T3 (es) * 2000-04-07 2014-05-30 Eiken Kagaku Kabushiki Kaisha Procedimiento de amplificación de ácido nucleico utilizando como molde ácido nucleico bicatenario
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7041447B2 (en) * 2001-04-09 2006-05-09 St. Jude Children's Hospital, Inc. Haplotyping method for multiple distal nucleotide polymorphisms
EP1319718A1 (en) * 2001-12-14 2003-06-18 Keygene N.V. High throughput analysis and detection of multiple target sequences
JP4517061B2 (ja) * 2003-08-08 2010-08-04 独立行政法人産業技術総合研究所 ダンベル型dnaの効率的な製造方法
JP4379087B2 (ja) * 2003-11-07 2009-12-09 トヨタ自動車株式会社 ゲラニルゲラニル二リン酸合成酵素及びゲラニルゲラニオールの製造方法
WO2005095654A1 (en) * 2004-03-25 2005-10-13 Biohelix Corporation Helicase-dependent amplification of circular nucleic acids
WO2006003721A1 (en) * 2004-07-02 2006-01-12 Kabushiki Kaisha Dnaform Method for preparing sequence tags
JP5438320B2 (ja) * 2005-10-03 2014-03-12 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 核酸を増幅するための組成物、方法およびキット
WO2009002891A1 (en) * 2007-06-22 2008-12-31 The Trustees Of Columbia University In The City Of New York Specific amplification of tumor specific dna sequences
CA3170924A1 (en) 2007-10-02 2009-04-09 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
WO2010127020A1 (en) * 2009-04-29 2010-11-04 Js Genetics Inc. Molecular diagnosis of fragile x syndrome associated with fmr1 gene
IT1394539B1 (it) * 2009-05-19 2012-07-05 Sentinel Ch S P A Uso di uno stabilizzante delle polimerasi per la liofilizzazione e la preparazione di kit pronti per l'uso
WO2012038049A2 (en) * 2010-09-22 2012-03-29 Roche Diagnostics Gmbh Amplification of distant nucleic acid targets using engineered primers
CN102242211A (zh) * 2011-07-08 2011-11-16 无锡锐奇基因生物科技有限公司 检测突变核酸序列的方法及试剂盒
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
EP2758510A4 (en) 2011-09-25 2015-05-06 Theranos Inc SYSTEMS AND METHOD FOR MULTILAYER ANALYSIS
US9809845B2 (en) * 2012-08-06 2017-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and reagents for amplifying nucleic acids
JP2014140367A (ja) * 2012-12-27 2014-08-07 Tosoh Corp B型肝炎ウイルスdna増幅用プライマーおよびそれを用いたb型肝炎ウイルスdna検出法
CN106715710B (zh) 2013-03-15 2022-10-25 赛拉诺斯知识产权有限责任公司 核酸扩增
MX370616B (es) * 2013-11-22 2019-12-17 Theranos Ip Co Llc Amplificacion de acidos nucleicos.
WO2016044673A1 (en) 2014-09-17 2016-03-24 Theranos, Inc. Hybrid multi-step nucleic acid amplification

Also Published As

Publication number Publication date
EP3194629A1 (en) 2017-07-26
CN113736863A (zh) 2021-12-03
EP3194590A1 (en) 2017-07-26
MX2017003473A (es) 2017-08-02
CN108026591A (zh) 2018-05-11
WO2016044673A1 (en) 2016-03-24
US20180223381A1 (en) 2018-08-09
US20160201148A1 (en) 2016-07-14
MX2017003475A (es) 2017-08-02
JP2021000138A (ja) 2021-01-07
MX366113B (es) 2019-06-26
US9909193B2 (en) 2018-03-06
JP2023011943A (ja) 2023-01-24
CN107002066A (zh) 2017-08-01
EP3194590A4 (en) 2018-05-09
CA2960859A1 (en) 2016-03-24
CA2961209A1 (en) 2016-03-24
CN108026591B (zh) 2021-09-07
US20170342476A1 (en) 2017-11-30
JP2022110152A (ja) 2022-07-28
WO2016044664A1 (en) 2016-03-24
JP2017531424A (ja) 2017-10-26
JP2017532030A (ja) 2017-11-02
EP3194629A4 (en) 2018-03-07
JP2021006056A (ja) 2021-01-21

Similar Documents

Publication Publication Date Title
HK1248284A1 (zh) 多重乳液核酸擴增
IL264555B (en) Specific primers for nucleic acid amplification
DK3129487T3 (da) Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression
IL241426A0 (en) Amplification of nucleic acids
IL241269B (en) Amplification of nucleic acids
GB201507119D0 (en) Nucleic Acid Construct
HK1243958A1 (zh) 核酸構建體
HK1244021A1 (zh) 核酸構建體
GB201507115D0 (en) Nucleic Acid Construct
GB201507111D0 (en) Nucleic acid construct
DK3094731T3 (da) Saccharidmodificerede nukleinsyremolekyler
HK1247255A1 (zh) 底數大於2的指數核酸擴增
EP3178919A4 (en) Nucleic acid amplification device
HK1250682A1 (zh) 核酸擴增
HK1232259A1 (zh) 核酸擴增
IL241273A0 (en) Amplification of nucleic acids
BR112017005392A2 (pt) amplificação de ácido nucleico multipassos híbrida
GB201415674D0 (en) Nucleic acid analysis
GB201409786D0 (en) Nucleic acid amplification system
GB201410223D0 (en) Nucleic acid amplification system
GB201402630D0 (en) Nucleic acid amplification
TH182610B (th) กรดนิวคลีอิกแอนทิเซนซ์
GB201402370D0 (en) Nucleic acid amplification system
TH1501007920B (th) ระบบจ่ายกำลังของยานพาหนะ
FI10873U1 (fi) Hybridilämmityslaite

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: THERANOS IP COMPANY, LLC (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25D Requested change of name of applicant approved

Owner name: LABRADOR DIAGNOSTICS LLC (US)

B25I Requirement for requested change of headquarter

Owner name: LABRADOR DIAGNOSTICS LLC (US)

Free format text: A FIM DE ATENDER A ALTERACAO DE ENDERECO CONFORME DOCUMENTOS APRESENTADOS ATRAVES DA PETICAO NO 870210077392 DE 23/08/2021, E NECESSARIO APRESENTAR UMA GUIA DE RECOLHIMENTO, CODIGO 248, ALEM DE ESCLARECER A DIVERGENCIA ENTRE O ENDERECO NO FORMULARIO E O ENDERECO NA DOCUMENTACAO APRESENTADA. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25G Requested change of headquarter approved

Owner name: LABRADOR DIAGNOSTICS LLC (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.